We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With an eye toward rare-disease research, the Biotechnology Industry Organization and a Duchenne patient advocacy group are joining forces to help drugmakers design clinical studies with patient input. Read More
A law firm that represents drugmakers is urging the FDA to rethink its stance on granting meetings with senior FDA officials, saying the agency’s policy can imperil drug research. Read More